Conditions: Breast Cancer
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 4
Healthy volunteers: no

Brief summary:
The purpose of the study is to assess the benefit of panobinostat monotherapy given either orally or i.v. to women with HER2-positive locally recurrent or metastatic breast cancer

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Panobinostat - LBH589 intervention 2: Panobinostat - LBH589
Intervention descriptions: intervention 1: Solution for infusion - 25mg/5ml intervention 2: Hard gelatine capsules - 5mg and 20 mg

Protocol document: